Through its sponsorship of The Ring Magazine LONDON, April 28, 2025 /PRNewswire/ -- Over the weekend, the UK fight scene welcomed a bold new contender as Saudi Arabia's first locally produced ...

Callback scams vie for top phishing vector position, SVG image files bypass defenses, and XRed is the malware family of the quarter LONDON, April 28, 2025 /PRNewswire/ -- VIPRE Security ...

Tech leaders report security solutions not delivering value for money with tools going unusedOver half of CIOs say their security patch systems are too complex to manage effectively and believe ...

On the evening of April 24, BlueFocus released its 2024 annual report, posting full-year revenue of RMB 60.797 billion, up 15.55% year-on-year. It is ...

Enersense International Plc | Stock Exchange Release | April 28, 2025 at 08:00:00 EEST Enersense International Plc, Business Review January-March 2025 The figures in this release are unaudited. The fi ...

Coalburn 1 is a 500MW construction-stage battery project, which is set to become the biggest of its kind in EuropeCOPENHAGEN, Denmark, April 28, 2025 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Part ...

Fourth Asia Pacific DNS Forum runs from 8 to 9 May 2025 HANOI, Vietnam, April 28, 2025 /PRNewswire/ -- The Internet Corporation for Assigned Names and Numbers (ICANN) will hold the fourth ...

Stockholm, Sweden - Cloetta, Northern Europe's leading confectionery company, announces plans to align its organisational structure with its new strategic priorities geared for profitable growth. At ...

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523) (NSE: BIOCON), today ...

This May Day, Ulike invites consumers to turn their time off into a moment of self-care with an exclusive offer on their advanced IPL hair removal devices ...

The world's #1 converged mobility event returns to ExCeL, London on 18-19 June, uniting the global mobility ecosystem for 2 days. MOVE provides an ...

Cycuria aims to revolutionise treatment of hard-to-treat blood cancers with a first-in-class protein-based therapeutic approach specifically targeting both tumour cells and tumour stem cellsAdvisory ...